MARKET

NVUS

NVUS

Novus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6380
-0.0050
-0.78%
Closed 16:00 01/24 EST
OPEN
0.6520
PREV CLOSE
0.6430
HIGH
0.7700
LOW
0.6000
VOLUME
541.40K
TURNOVER
--
52 WEEK HIGH
5.21
52 WEEK LOW
0.4000
MARKET CAP
8.28M
P/E (TTM)
-0.4053
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NVUS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NVUS News

  • Novus Therapeutics Provides Update on OP0201
  • Business Wire.01/13 11:30
  • Novus Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds
  • Business Wire.01/10 22:19
  • Hedge Funds Have Never Been More Bullish On Novus Therapeutics, Inc. (NVUS)
  • Insider Monkey.12/22/2019 18:51
  • Novus Therapeutics to Participate in Two Investor Conferences
  • Business Wire.11/29/2019 13:30

More

Industry

Pharmaceuticals
-1.84%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About NVUS

Novus Therapeutics, Inc., formerly Tokai Pharmaceuticals, Inc., is a pharmaceutical company. The Company is focused on the acquisition, development, and commercialization of ear, nose, and throat products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-01 is currently being developed as an improved treatment option for acute otitis externa. OP-02 is a daily nasal spray that is designed to improve and maintain a healthy middle ear. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction. OP-02 is a combination drug product, which comprises two components: surfactant dipalmitoylphosphatidylcholine and a spreading agent cholesteryl palmitate. The product is sprayed through the nostrils toward the opening of the Eustachian tube at the back of the nasal cavity.
More

Webull offers Novus Therapeutics Inc (NVUS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.